TREATMENT OF NON-BIOLOGIC-DMARD-IR PSA PATIENTS WITH UPADACITINIB OR ADALIMUMAB RESULTS IN THE MODULATION OF DISTINCT FUNCTIONAL PATHWAYS: PROTEOMICS ANALYSIS OF THE SELECT-PSA 1 PHASE 3 STUDY

被引：0
|
作者：
Sornasse, T. [1 ]
Anderson, J. [2 ]
Kato, K. [2 ]
Lertratanakul, A. [2 ]
Ritchlin, C. T. [3 ]
McInnes, I. [4 ]
机构：
[1] AbbVie, Precis Med Immunol, Redwood City, CA USA
[2] AbbVie, Immunol Clin Dev, N Chicago, IL USA
[3] Univ Rochester, Allergy Immunol & Rheumatol, Rochester, NY USA
[4] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2021年 / 80卷
关键词：
D O I：
10.1136/annrheumdis-2021-eular.1462
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0030
引用
收藏
页码：16 / 16
页数：1
相关论文
共 42 条
  • [1] Treatment of Non-biologic-DMARD-IR PsA Patients with Upadacitinib or Adalimumab Results in the Modulation of Distinct Functional Pathways: Proteomics Analysis of a Phase 3 Study
    Sornasse, Thierry
    Anderson, Jaclyn
    Kato, Koji
    Lertratanakul, Apinya
    Ritchlin, Christopher
    McInnes, Iain
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3788 - 3789
  • [2] PROTEOMICS ANALYSIS COMPARING THE MODE OF ACTION OF UPADACITINIB BETWEEN NON-BIOLOGICDMARD-IR AND BIOLOGIC-DMARD-IR PsA PATIENTS IDENTIFIES DISTINCT PATHOGENIC PATHWAYS IN THE SELECT-PsA 1 AND SELECT-PsA 2 PHASE 3 STUDIES
    Sornasse, T.
    Anderson, J.
    Kato, K.
    Lertratanakul, A.
    McInnes, I.
    Ritchlin., C. T.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 433 - 433
  • [3] EFFICACY OF UPADACITINIB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND A LOW OR HIGH SWOLLEN JOINT COUNT: A SUBGROUP ANALYSIS OF 2 PHASE 3 STUDIES (SELECT-PsA 1 AND SELECT-PsA 2)
    Gossec, L.
    Gladman, D. D.
    Mcdearmon-Blondell, E.
    Sewerin, P.
    Ritchlin, C. T.
    Feng, D.
    Lertratanakul, A.
    Ranza, R.
    Tam, L. S.
    Marchesoni, A.
    Coates, L. C.
    Nash, P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1308 - 1309
  • [4] Efficacy and Safety of Upadacitinib in Patients with Psoriatic Arthritis: 2-Year Results from the Phase 3 SELECT-PsA 1 Study
    McInnes, Iain B.
    Kato, Koji
    Magrey, Marina
    Merola, Joseph F.
    Kishimoto, Mitsumasa
    Haaland, Derek
    Chen, Liang
    Duan, Yuanyuan
    Liu, Jianzhong
    Lippe, Ralph
    Wung, Peter
    [J]. RHEUMATOLOGY AND THERAPY, 2023, 10 (01) : 275 - 292
  • [5] Efficacy and Safety of Upadacitinib in Patients with Psoriatic Arthritis: 2-Year Results from the Phase 3 SELECT-PsA 1 Study
    Iain B. McInnes
    Koji Kato
    Marina Magrey
    Joseph F. Merola
    Mitsumasa Kishimoto
    Derek Haaland
    Liang Chen
    Yuanyuan Duan
    Jianzhong Liu
    Ralph Lippe
    Peter Wung
    [J]. Rheumatology and Therapy, 2023, 10 : 275 - 292
  • [6] DIFFERENTIATION BETWEEN IL-6 AND IL-17 PATHWAY INHIBITION IN RELATIONSHIP WITH CLINICAL OUTCOMES IN NON-BIOLOGICAL DMARD-IR AND BIOLOGICAL DMARD-IR PSORIATIC ARTHRITIS PATIENTS TREATED WITH UPADACITINIB IN SELECT-PSA 1 AND SELECT-PSA 2 STUDIES
    Cai, F.
    Sornasse, T.
    Ruzek, M.
    Fang, Y.
    Kato, K.
    Wung, P.
    McInnes, I.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 17 - 18
  • [7] EFFICACY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS STRATIFIED BY INVOLVEMENT OF WEIGHT-BEARING JOINT REGIONS: A POST HOC SUBGROUP ANALYSIS OF THE PHASE 3, RANDOMIZED, SELECT-PSA 1 AND SELECT-PSA 2 TRIALS
    Mizelle, K.
    Tillett, W.
    Ali, M.
    Iyile, T.
    Gao, T.
    Setty, A.
    Walsh, J. A.
    Coates, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1767 - 1768
  • [8] Efficacy of Upadacitinib in Patients with Psoriatic Arthritis Stratified by Involvement of Weight-bearing Joint Regions: A Post Hoc Subgroup Analysis of the Phase 3, Randomized, SELECT-PsA 1 and SELECT-PsA 2 Trials
    Mizelle, Kristi
    Tillett, William R.
    Ali, Mira
    Iyile, Thomas
    Gao, Tianming
    Setty, Arathi
    Walsh, Jessica A.
    Coates, Laura
    [J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2805 - 2806
  • [9] LONG-TERM EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS: 3-YEAR RESULTS FROM THE PHASE 3 SELECT-PSA 1 STUDY
    Mcinnes, I.
    Kato, K.
    Magrey, M.
    Merola, J. F.
    Kishimoto, M.
    Haaland, D.
    Li, Y.
    Liu, Y.
    Liu, J.
    Lippe, R.
    Wung, P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1137 - 1138
  • [10] Improvement in Patient-Reported Outcomes in Patients with Psoriatic Arthritis Treated with Upadacitinib Versus Placebo or Adalimumab: Results from SELECT-PsA 1
    Strand, Vibeke
    Mease, Philip J.
    Soriano, Enrique R.
    Kishimoto, Mitsumasa
    Salvarani, Carlo
    Saffore, Christopher D.
    Zueger, Patrick
    McDearmon-Blondell, Erin
    Kato, Koji
    Gladman, Dafna D.
    [J]. RHEUMATOLOGY AND THERAPY, 2021, 8 (04) : 1789 - 1808
12345